Austria
The article provides a general overview of the regulatory framework for combination products applicable in the EU in general and in Austria specifically.
Denmark
The article outlines the key points to be included in the application for authorization to conduct clinical trials in Denmark.
FDA
The new article refers to additional resources to be taken into consideration by the parties involved in operations with laboratory-developed tests.
EU
The new article describes in detail the approach to be applied when it comes to the re-assessment of designation under the new regulatory framework.
EU
The new article highlights certain specific aspects associated with designation, such as notification procedure or changes to the scope of designation.
